Medolution Ltd.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Keynatinib in Treated Patients With NSCLC and Brain Metastases (NCT04824079) | Medolution Ltd. | 2020-10-21 |
Track Medolution Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.